Stock listing
Thalia Therapeutics Plc
Selected listing: 0GO · SWB · EUR · DE
Thalia Therapeutics Plc (Stuttgart:0GO), Health Technology. Latest release Sep 30, 2026: Interim Results.
- Ticker
- Stuttgart:0GO
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Stuttgart
- Currency
- EUR
About Thalia Therapeutics Plc
The company focuses on developing innovative therapeutic solutions. Thalia Therapeutics aims to address unmet medical needs through its research and development efforts.
Latest news from Thalia Therapeutics Plc
Events
Replays
THALIA THERAPEUTICS PLC (THAT) — Interim results for the six months ended 30 June 2026
Wed, Sep 30, 2026 · 09:00 AM ET
WatchTHALIA THERAPEUTICS PLC (THAT) — Investor Presentation
Wed, Jun 24, 2026 · 09:00 AM ET
WatchTHALIA THERAPEUTICS PLC (THAT) — Interim results for the six months ended 30 June 2025
Thu, Sep 25, 2025 · 09:00 AM ET
Watch
Research Thalia Therapeutics Plc
Thalia Therapeutics Plc company profile
View the public company page for Thalia Therapeutics Plc on 6ix.
Thalia Therapeutics Plc news
Read company news and market updates connected to Thalia Therapeutics Plc.
Thalia Therapeutics Plc investor events
Find investor webinars, events, and replay context for Thalia Therapeutics Plc.
Alternate listings
THAT:LSE
GB · GBX
Alternate listing for Thalia Therapeutics Plc; the primary context on this page is 0GO:SWB.
A2DQES:LSX
DE · EUR
Alternate listing for Thalia Therapeutics Plc; the primary context on this page is 0GO:SWB.
A2DQES:LS
DE · EUR
Alternate listing for Thalia Therapeutics Plc; the primary context on this page is 0GO:SWB.
THAT.GB:AQUIS
GB · GBX
Alternate listing for Thalia Therapeutics Plc; the primary context on this page is 0GO:SWB.
0GO:FWB
DE · EUR
Alternate listing for Thalia Therapeutics Plc; the primary context on this page is 0GO:SWB.